Evidence map›Paper›PMID 28202061›Full record

ArticleStem cell research & therapy2017

In vitro generation of Sertoli-like and haploid spermatid-like cells from human umbilical cord perivascular cells.

Ekaterina Shlush, Leila Maghen, Sonja Swanson, Shlomit Kenigsberg, Sergey Moskovtsev, Tanya Barretto, Andrée Gauthier-Fisher, Clifford L Librach

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Current status and reflections on fertility preservation in China.Journal of assisted reproduction and genetics · 2022
    Review
  10. Frontiers in cell and developmental biology · 2022
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Pluripotent Cell Models for Gonadal Research.International journal of molecular sciences · 2019
    Review
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ekaterina ShlushCReATe Fertility Centre, 790 Bay Street, Toronto, Ontario, M5N 1G8, Canada. ekaterinashlush@gmail.com.
Leila MaghenCReATe Fertility Centre, 790 Bay Street, Toronto, Ontario, M5N 1G8, Canada.
Sonja SwansonCReATe Fertility Centre, 790 Bay Street, Toronto, Ontario, M5N 1G8, Canada.
Shlomit KenigsbergCReATe Fertility Centre, 790 Bay Street, Toronto, Ontario, M5N 1G8, Canada.
Sergey MoskovtsevCReATe Fertility Centre, 790 Bay Street, Toronto, Ontario, M5N 1G8, Canada.
Tanya BarrettoCReATe Fertility Centre, 790 Bay Street, Toronto, Ontario, M5N 1G8, Canada.
Andrée Gauthier-FisherCReATe Fertility Centre, 790 Bay Street, Toronto, Ontario, M5N 1G8, Canada.
Clifford L LibrachCReATe Fertility Centre, 790 Bay Street, Toronto, Ontario, M5N 1G8, Canada. drlibrach@createivf.com.
CReATe Fertility Centre · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFirst trimester (FTM) and term human umbilical cord-derived perivascular cells (HUCPVCs), which are rich sources of mesenchymal stem cells (MSCs), can give rise to Sertoli cell (SC)-like as well as haploid germ cell (GC)-like cells in vitro using culture conditions that recapitulate the testicular niche. Gamete-like cells have been produced ex vivo using pluripotent stem cells as well as MSCs. However, the production of functional gametes from human stem cells has yet to be achieved.

methodsThree independent lines of FTM and term HUCPVCs were cultured using a novel 5-week step-wise in vitro differentiation protocol recapitulating key physiological signals involved in testicular development. SC- and GC-associated phenotypical properties were assessed by real-time polymerase chain reaction (RT-PCR), quantitative PCR immunocytochemistry, flow cytometry, and fluorescence in-situ hybridization (FISH). Functional spermatogonial stem cell-like properties were assessed using a xenotranplantation assay.

resultsWithin 3 weeks of differentiation, two morphologically distinct cell types emerged including large adherent cells and semi-attached round cells. Both early GC-associated markers (VASA, DAZL, GPR125, GFR1α) and SC-associated markers (FSHR, SOX9, AMH) were upregulated, and 5.7 ± 1.2% of these cells engrafted near the inner basal membrane in a xenograft assay. After 5 weeks in culture, 10-30% of the cells were haploid, had adopted a spermatid-like morphology, and expressed PRM1, Acrosin, and ODF2. Undifferentiated HUCPVCs secreted key factors known to regulate spermatogenesis (LIF, GDNF, BMP4, bFGF) and 10-20% of HUCPVCs co-expressed SSEA4, CD9, CD90, and CD49f. We hypothesize that the paracrine properties and cellular heterogeneity of HUCPVCs may explain their dual capacity to differentiate to both SC- and GC-like cells.

conclusionsHUCPVCs recapitulate elements of the testicular niche including their ability to differentiate into cells with Sertoli-like and haploid spermatid-like properties in vitro. Our study supports the importance of generating a niche-like environment under ex vivo conditions aiming at creating mature GC, and highlights the plasticity of HUCPVCs. This could have future applications for the treatment of some cases of male infertility.

Indexed as

AnimalsBiomarkersCell DifferentiationFetal BloodGene ExpressionGene Expression ProfilingHeterograftsHumansMaleMesenchymal Stem CellsMiceMice, SCIDParacrine CommunicationPrimary Cell CultureSertoli CellsSpermatidsBiomarkersEx-vivo spermatogenesisGerm cellHuman mesenchymal stem cellHuman umbilical cordNicheParacrinePerivascular cellSertoli cellSpermatogonial stem cellXenograft

Identifiers

PMID28202061
PMCPMC5312448
OpenAlexW2588949194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.